CIK 0001125345 · Non-accelerated filer<br>Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $129,086
- in 1 filing, $129K under 10b5-1 plans
Net −$129,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-20 | Chhabra Meenu Director | Option exercise · Restricted Stock Unit | −4,500 | 0 | ||
| 2024-05-20 | Ferrante Karen Jean Director | Option exercise | +4,500 | 4,500 | ||
| 2024-05-20 | Ferrante Karen Jean Director | Option exercise · Restricted Stock Unit | −4,500 | 0 | ||
| 2024-05-20 | HURWITZ EDWARD Director | Option exercise | +4,500 | 37,574 | ||
| 2024-05-20 | HURWITZ EDWARD Director | Option exercise · Restricted Stock Unit | −4,500 | 0 | ||
| 2024-04-04 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise 10b5-1 | +42,500 | $4.82 | $205K | 51,395 |
| 2024-04-04 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale 10b5-1 | −42,500 | $15.07 | $640K | 8,895 |
| 2024-04-04 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale 10b5-1 | −147 | $15.51 | $2K | 8,748 |
| 2024-04-04 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale 10b5-1 | −232 | $16.38 | $4K | 8,516 |
| 2024-04-04 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale 10b5-1 | −5,351 | $17.74 | $95K | 3,165 |
| 2024-04-04 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale 10b5-1 | −3,165 | $18.22 | $58K | 0 |
| 2024-04-04 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise · Employee stock option (right to buy) 10b5-1 | −42,500 | $4.82 | $205K | 127,500 |
| 2024-03-06 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise 10b5-1 | +10,875 | $11.50 | $125K | 19,770 |
| 2024-03-06 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise 10b5-1 | +8,750 | $10.15 | $89K | 28,520 |
| 2024-03-06 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale 10b5-1 | −19,625 | $21.50 | $422K | 8,895 |
| 2024-03-06 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise · Employee stock option (right to buy) 10b5-1 | −10,875 | $11.50 | $125K | 0 |
| 2024-03-06 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise · Employee stock option (right to buy) 10b5-1 | −8,750 | $10.15 | $89K | 39,375 |
| 2024-03-04 | Risser Eric Blasius Chief Operating Officer | Option exercise 10b5-1 | +15,000 | $10.15 | $152K | 80,059 |
| 2024-03-04 | Risser Eric Blasius Chief Operating Officer | Sale 10b5-1 | −15,000 | $20.00 | $300K | 65,059 |
| 2024-03-04 | Risser Eric Blasius Chief Operating Officer | Sale 10b5-1 | −26,159 | $19.63 | $514K | 38,900 |
Page 14 of 17 · 322 trades